Nb rat prostate adenocarcinoma model androgen-sensitive tumor: metastasis control.

Publication/Presentation Date

9-1-1983

Abstract

In this preliminary report, evaluation of nontraditional agents has been used to evaluate control of metastasis. This androgen-sensitive rate prostatic adenocarcinoma has been subject to the treatments of heparin, indocin, and castration, as well as combinations of castration, heparin, indocin, and cyclophosphamide. Tumor volume, metastasis, and determination of regression of primary tumor have been evaluated. Heparin and indocin both reduced metastasis without affecting tumor volume in this study. The combination of castration and cyclophosphamide was most effective in reducing tumor volume when compared to the other groups.

Volume

24

Issue

1

First Page

33

Last Page

35

ISSN

0022-4790

Disciplines

Medicine and Health Sciences

PubMedID

6887934

Department(s)

Department of Surgery

Document Type

Article

Share

COinS